Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates

分组1 - Agilon Health reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.28, and compared to a loss of $0.14 per share a year ago, indicating a significant decline in performance [1] - The company achieved revenues of $1.06 billion for the quarter, surpassing the Zacks Consensus Estimate by 0.72%, and showing a substantial increase from $689.77 million in the same quarter last year [1] - Agilon has only surpassed consensus EPS estimates once in the last four quarters, indicating challenges in meeting earnings expectations [1] 分组2 - Agilon shares have decreased by approximately 50.8% since the beginning of the year, contrasting with the S&P 500's gain of 6.3%, highlighting underperformance in the market [2] - The current consensus EPS estimate for the upcoming quarter is $0.07 on revenues of $1.57 billion, while for the current fiscal year, the estimate is -$0.10 on revenues of $6.38 billion [4] - The Medical Services industry, to which Agilon belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable industry outlook that could impact Agilon's performance [4]